Veeva Systems Inc. $VEEV Shares Bought by Andra AP fonden

Andra AP fonden grew its position in Veeva Systems Inc. (NYSE:VEEV) by 100.4% during the 4th quarter, Holdings Channel reports. The fund owned 115,017 shares of the technology company’s stock after buying an additional 57,617 shares during the quarter. Andra AP fonden’s holdings in Veeva Systems were worth $25,675,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in VEEV. Board of the Pension Protection Fund purchased a new stake in Veeva Systems during the fourth quarter worth about $27,000. Raiffeisen Bank International AG acquired a new position in Veeva Systems during the third quarter worth about $28,000. Newbridge Financial Services Group Inc. raised its position in Veeva Systems by 322.6% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock worth $29,000 after acquiring an additional 100 shares during the last quarter. Activest Wealth Management raised its position in Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock worth $29,000 after acquiring an additional 127 shares during the last quarter. Finally, BOK Financial Private Wealth Inc. acquired a new position in Veeva Systems during the fourth quarter worth about $33,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Insider Transactions at Veeva Systems

In related news, Director Priscilla Hung sold 750 shares of the stock in a transaction dated Thursday, April 30th. The shares were sold at an average price of $155.64, for a total value of $116,730.00. Following the completion of the transaction, the director owned 3,253 shares in the company, valued at $506,296.92. This represents a 18.74% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by corporate insiders.

Veeva Systems Stock Down 1.4%

VEEV opened at $161.54 on Friday. The company has a market cap of $26.38 billion, a P/E ratio of 28.80, a P/E/G ratio of 0.70 and a beta of 0.95. The company has a 50 day moving average of $165.32 and a two-hundred day moving average of $192.34. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Wednesday, June 3rd. The technology company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. The company had revenue of $882.95 million for the quarter, compared to analysts’ expectations of $857.73 million. During the same period in the prior year, the company earned $1.97 earnings per share. The firm’s revenue was up 16.3% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. Research analysts anticipate that Veeva Systems Inc. will post 6.65 earnings per share for the current year.

Key Stories Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva’s latest quarter was described as strong, with broad-based customer demand, solid execution across R&D and commercial products, and continued momentum in Vault CRM migrations and AI-driven offerings. Reasons to Add Veeva Systems Stock to Your Portfolio for Now
• Positive Sentiment: The company continues to expand its AI strategy, including the Falcon platform and “agentic labor” tools, which management says could improve automation and deepen its competitive moat in life sciences software. The 5 Most Interesting Analyst Questions From Veeva Systems’s Q1 Earnings Call
• Positive Sentiment: Veeva announced that UCB is standardizing global pharmacovigilance operations on the Veeva Safety Suite, reinforcing customer adoption of its regulated-cloud products. UCB vereinheitlicht seine weltweiten Pharmakovigilanz-Aktivitäten mit der Veeva Safety Suite
• Neutral Sentiment: Several recent articles say VEEV is one of the most watched stocks on Zacks, suggesting rising investor interest, but these pieces do not point to a specific new catalyst. Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
• Neutral Sentiment: One article noted the stock remains well below its prior highs after a steep one-year decline, which may support a value/rebound narrative but also reflects lingering investor caution. Is It Time To Revisit Veeva Systems (VEEV) After A 41% One Year Share Price Decline
• Negative Sentiment: Despite the upbeat product and earnings backdrop, analysts and commentary continue to flag saturation risk in the life sciences CRM market, which could limit long-term upside. Reasons to Add Veeva Systems Stock to Your Portfolio for Now

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Robert W. Baird lifted their target price on shares of Veeva Systems from $250.00 to $260.00 and gave the stock an “outperform” rating in a research report on Thursday, June 4th. Truist Financial reissued a “buy” rating and issued a $262.00 price objective (down from $275.00) on shares of Veeva Systems in a research report on Thursday, March 5th. Zacks Research lowered shares of Veeva Systems from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 14th. The Goldman Sachs Group cut their price objective on shares of Veeva Systems from $190.00 to $165.00 and set a “sell” rating for the company in a research report on Thursday, June 4th. Finally, Royal Bank Of Canada reissued an “outperform” rating and issued a $275.00 price objective on shares of Veeva Systems in a research report on Thursday, June 4th. Eighteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $250.96.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.